Skip to main content
3-D Matrix,Ltd. logo

3-D Matrix,Ltd. — Investor Relations & Filings

Ticker · 7777 ISIN · JP3410730000 T Manufacturing
Filings indexed 69 across all filing types
Latest filing 2025-12-11 Regulatory Filings
Country JP Japan
Listing T 7777

About 3-D Matrix,Ltd.

https://3dmatrix.com/

3-D Matrix, Ltd. is a global medical technology company specializing in the development and commercialization of products based on a proprietary self-assembling peptide technology. Originating from research at the Massachusetts Institute of Technology (MIT), this platform creates biocompatible hydrogels used primarily as hemostatic agents to control oozing bleeding during surgical and endoscopic procedures. The company's solutions are applied across various medical specialties, including gastroenterology, cardiac surgery, otolaryngology (ENT), and urology. 3-D Matrix is also advancing its peptide platform to develop new applications in wound healing, regenerative medicine, and drug delivery systems, aiming to provide clinically proven solutions that improve patient outcomes.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of a Semi-Annual Report (Hankishokokusho) for the period ending October 31, 2025. Since this is a regulatory filing confirming the accuracy of financial reporting and does not fit into the specific categories of the reports themselves (like 10-K or IR), it falls under the general regulatory filing category.
2025-12-11 Japanese
半期報告書-第22期(2025/05/01-2026/04/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis, and business information for the interim period (2025-05-01 to 2025-10-31). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2025-12-11 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It serves as a formal certification by the CEO/CFO regarding the accuracy of the company's Annual Securities Report (Yuuka Shouken Houkokusho). Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into specific categories like 'RPA' or '10-K', it falls under the general regulatory filing category. FY 2025
2025-07-24 Japanese
有価証券報告書-第21期(2024/05/01-2025/04/30)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending April 30, 2025. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2025
2025-07-24 Japanese
有価証券届出書(参照方式)
Capital/Financing Update Classification · 1% confidence The document is titled "有価証券届出書" (Securities Registration Statement) and is submitted to the "関東財務局長" (Kanto Local Finance Bureau Director) on June 24, 2025. It details the offering of a new type of security: "新株予約権付社債" (Convertible Bonds with Stock Acquisition Rights), specifically the 9th unsecured convertible bond type. The content extensively covers the terms of the offering, including issue price, maturity date, conversion price adjustments, and the purpose of the financing (refinancing existing convertible bonds). This structure and content strongly indicate a filing related to the issuance or offering of securities, which aligns with the regulatory filing category for securities registration statements or prospectuses. In the provided definitions, this type of comprehensive offering document, especially one detailing capital structure changes and fundraising, best fits the 'Capital/Financing Update' (CAP) category, as it is a formal filing announcing a major financing event. While it is a regulatory filing, 'CAP' is more specific than the general 'RNS'. It is not a 10-K (Annual Report), ER (Earnings Release), or IR (Interim Report).
2025-06-24 Japanese
臨時報告書
Regulatory Filings Classification · 1% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau ('関東財務局長'). The filing reason explicitly states that it is submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and relevant Cabinet Office Ordinance provisions due to an event significantly impacting the company's financial condition, operating results, and cash flow. The content details specific financial adjustments (exchange rate differences, interest expenses, bond redemption losses, impairment losses) recognized on the date of the Board resolution (June 12, 2025), relating to the fiscal year ending April 2025. This structure—a formal, unscheduled filing detailing a significant, non-periodic financial event—is characteristic of a Japanese 'Extraordinary Report' (Tōjō Hōkokusho), which generally corresponds to the SEC's 8-K filing in function. Among the provided codes, 'RNS' (Regulatory Filings) is the most appropriate general category for miscellaneous, unscheduled regulatory disclosures that do not fit the specific periodic reports (10-K, IR) or specific event types (DIV, M&A, etc.). Since 'Extraordinary Report' is not a specific code, RNS serves as the best fit for this type of material event disclosure.
2025-06-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.